The French healthtech sector demonstrated resilience in 2022, raising €2.6 billion, a 14% increase from 2021, despite a 45% drop in market capitalization. Venture capital financing, particularly in e-health, biotech, and medtech, remained robust, with €1.8 billion raised across 16 significant deals. IPOs contributed €198 million, but venture capital continued to dominate funding sources, reflecting a shift in investor focus towards bio-manufacturing and CDMO activities.